Literature DB >> 15311928

Structural relationship of lithocholic acid derivatives binding to the N-terminal 8-kDa domain of DNA polymerase beta.

Yoshiyuki Mizushina1, Nobuyuki Kasai, Katsumi Miura, Shinya Hanashima, Masaharu Takemura, Hiromi Yoshida, Fumio Sugawara, Kengo Sakaguchi.   

Abstract

We reported previously that lithocholic acid (LCA, 3-alpha-hydroxy-5-beta-cholan-24-oic acid), one of the major compounds in the secondary bile acids, selectively inhibited the activity of mammalian DNA polymerase beta (pol beta) [Mizushina, Y., Ohkubo, T., Sugawara, F., and Sakaguchi, K. (2000) Biochemistry 39, 12606-12613]. The purpose of this study was to investigate the molecular structural relationship of LCA and its 10 chemically synthesized derivatives. The inhibitory activities of pol beta by some derivative compounds were stronger than that by LCA, and these compounds bound tightly to the 8-kDa domain fragment but not to the 31-kDa domain fragment of pol beta. Biacore analysis demonstrated that the 8-kDa domain bound selectively to compound 9 (3-alpha-O-lauroyl-5-beta-cholan-24-oic acid), which was the strongest pol beta inhibitor tested, as a 1:1 complex with a dissociation constant (K(d)) of 1.73 nM. From computer modeling analysis (i.e., molecular dynamics analysis), the 8-kDa domain had two inhibitor binding areas. Three amino acid residues (Lys60, Leu77, and Thr79) of the 8-kDa domain bound to LCA and compound 2 (3-alpha-methoxy-5-beta-cholan-24-oic acid), and four amino acid residues (Leu11, Lys35, His51, and Thr79) of the 8-kDa domain bound to compound 9. From these results, the structure-function relationship among pol beta and its selective inhibitors was discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15311928     DOI: 10.1021/bi049307r

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  5 in total

Review 1.  Targeting DNA polymerase ß for therapeutic intervention.

Authors:  Eva M Goellner; David Svilar; Karen H Almeida; Robert W Sobol
Journal:  Curr Mol Pharmacol       Date:  2012-01       Impact factor: 3.339

Review 2.  Obesity and cancer: A mechanistic overview of metabolic changes in obesity that impact genetic instability.

Authors:  Pallavi Kompella; Karen M Vasquez
Journal:  Mol Carcinog       Date:  2019-06-05       Impact factor: 4.784

3.  Structural determinants of monohydroxylated bile acids to activate beta 1 subunit-containing BK channels.

Authors:  Anna N Bukiya; Jacob McMillan; Abby L Parrill; Alejandro M Dopico
Journal:  J Lipid Res       Date:  2008-07-23       Impact factor: 5.922

4.  Calcium- and voltage-gated potassium (BK) channel activators in the 5β-cholanic acid-3α-ol analogue series with modifications in the lateral chain.

Authors:  Anna N Bukiya; Shivaputra A Patil; Wei Li; Duane D Miller; Alex M Dopico
Journal:  ChemMedChem       Date:  2012-09-04       Impact factor: 3.466

5.  Synthesis and Anticancer Activity of Hybrid Molecules Based on Lithocholic and (5Z,9Z)-Tetradeca-5,9-dienedioic Acids Linked via Mono(di,tri,tetra)ethylene Glycol and α,ω-Diaminoalkane Units.

Authors:  Vladimir A D'yakonov; Regina A Tuktarova; Lilya U Dzhemileva; Svetlana R Ishmukhametova; Usein M Dzhemilev
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.